Senzime Expands TetraGraph's Clinical Use Beyond Surgery Into Brain ...
(PR-inside.com) UPPSALA, SE / ACCESS Newswire / November 5, 2026 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF), a global leader in precision-based patient monitoring, today announced the expanded clinical use of its TetraGraph® system in electroconvulsive therapy (ECT), a form of brain stimulation treatment for certain s…
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


